Coronary microvascular dysfunction in primary cardiomyopathies

Heart

Volumn 100, Issue 10, 2014, Pages 806-813

  Spoladore, Roberto ^a   Fisicaro, A ^b   Faccini, A ^b   Camici, P G ^a,b  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARTERY INTIMA PROLIFERATION; ARTICLE; CAPILLARY DENSITY; CARDIOMYOPATHY; CONGESTIVE CARDIOMYOPATHY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DILATATION; CORONARY ARTERY DISEASE; CORONARY FLOW RESERVE; CORONARY MICROVASCULAR DYSFUNCTION; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; ENDOTHELIAL DYSFUNCTION; FABRY DISEASE; HEART ARRHYTHMIA; HEART FAILURE; HEART MUSCLE BLOOD FLOW; HEART MUSCLE FIBROSIS; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; HEART RIGHT VENTRICLE DYSPLASIA; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MICROANGIOPATHY; MICROCIRCULATION; MICROVASCULAR ISCHEMIA; PATHOGENESIS; PRIORITY JOURNAL; RISK FACTOR; TAKOTSUBO CARDIOMYOPATHY; VENTRICULAR NONCOMPACTION;

CORONARY PHYSIOLOGY;

CARDIOMYOPATHIES; CORONARY CIRCULATION; CORONARY VESSELS; HUMANS; MICROCIRCULATION;

EID: 84899625402     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2013-304291     Document Type: Article

References (20)

1. Camici PG, Crea F. Coronary microvascular dysfunction. N Engl J Med 2007;356:830-40
2. Maron BJ, Towbin JA, Thiene G, et al. Contemporary definitions and classification of the cardiomyopathies. An American Heart Association scientific statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation 2006;113:1807-16
3. Elliott P, Andersson B, Arbustini E, et al. Classification of the cardiomyopathies: a position statement from the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 2008;29:270-6
4. Maron MS, Olivotto I, Maron BJ, et al. The case for myocardial ischemia in hypertrophic cardiomyopathy. J Am Coll Cardiol 2009;54:866-75
5. Camici P, Chiriatti G, Lorenzoni R, et al. Coronary vasodilation is impaired in both hypertrophied and non-hypertrophied myocardium of patients with hypertrophic cardiomyopathy: a study with nitrogen-13ammonia and positron emission tomography. J Am Coll Cardiol 1991;17:879-86
6. Cecchi F, Olivotto I, Gistri R, et al. Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy. N Engl J Med 2003;349:1027-35 (Pubitemid 37087617)
7. Olivotto I, Girolami F, Sciagrà R, et al. Microvascular function is selectively impaired in patients with hypertrophic cardiomyopathy and sarcomere myofilament gene mutations. J Am Coll Cardiol 2011;58:839-48
8. Kwon DH, Smedira NG, Rodriguez ER, et al. Cardiac magnetic resonance detection of myocardial scarring in hypertrophic cardiomyopathy: correlation with histopathology and prevalence of ventricular tachycardia. J Am Coll Cardiol 2009;54: 242-9
9. Neglia D, Parodi O, Gallopin M, et al. Myocardial blood flow response to pacing tachycardia and to dipyridamole infusion in patients with dilated cardiomyopathy without overt heart failure. A quantitative assessment by positron emission tomography. Circulation 1995;92:796-804
10. Inoue T, Sakai Y, Morooka S, et al. Coronary flow reserve in patients with dilated cardiomyopathy. Am Heart J 1993;125:93-8 (Pubitemid 23021630)
11. Koutalas E, Kanoupakis E, Vardas P. Sudden cardiac death in non-ischemic dilated cardiomyopathy: a critical appraisal of existing and potential risk stratification tools. Int J Cardiol 2013;167:335-41
12. Paul M, Rahbar K, Gerss J, et al. Microvascular dysfunction in nonfailing arrhythmogenic right ventricular cardiomyopathy. Eur J Nucl Med Mol Imaging 2012;39:416-20
13. Wichter T, Schäfers M, Rhodes CG, et al. Abnormalities of cardiac sympathetic innervation in arrhythmogenic right ventricular cardiomyopathy: quantitative assessment of presynaptic norepinephrine reuptake and postsynaptic beta-adrenergic receptor density with positron emission tomography. Circulation 2000;101:1552-8 (Pubitemid 30180892)
14. Jenni R, Oechslin EN, van der Loo B. Isolated ventricular noncompaction of the myocardium in adults. Heart 2007;93:11-15 (Pubitemid 46094038)
15. Jenni R, Wyss CA, Oechslin EN, et al. Isolated ventricular noncompaction is associated with coronary microcirculatory dysfunction. J Am Coll Cardiol 2002;39:450-4 (Pubitemid 34117502)
16. Galiuto L, De Caterina AR, Porfidia A, et al. Reversible coronary microvascular dysfunction: a common pathogenetic mechanism in apical ballooning or tako-tsubo syndrome. Eur Heart J 2010;31:1319-27
17. Chambliss KL, Shaul PW. Estrogen modulation of endothelial nitric oxide synthase. Endocr Rev 2002;23:665-86 (Pubitemid 35191628)
18. Mori H, Ishikawa S, Kojima S, et al. Increased responsiveness of left ventricular apical myocardium to adrenergic stimuli. Cardiovasc Rev 1993;27:192-8 (Pubitemid 23070327)
19. Elliott PM, Kindler H, Shah JS, et al. Coronary microvascular dysfunction in male patients with Anderson-Fabry disease and the effect of treatment with a galactosidase A. Heart 2006;92:357-60
20. Chimenti C, Morgante E, Tanzilli G, et al. Angina in Fabry disease reflects coronary small vessel disease. Circ Heart Fail 2008;1:161-9